Seer (SEER) Other financing activities (2020 - 2026)

Seer (SEER) posted quarterly Other financing activities of $14000.0 for Q1 2026, down 92.67% quarter-over-quarter from $191000.0 in Q4 2025.

Seer (SEER) Other financing activities (2020 - 2026) Analysis & Trends

Seer's Other financing activities history runs 7 years deep, the most recent figure standing at $14000.0 for Q1 2026.

In Q1 2026, Other financing activities changed N/A year-over-year to $14000.0; the TTM figure through Mar 2026 stood at $416000.0 (changed N/A YoY), while the FY2025 annual figure was $402000.0, changed N/A from the prior year.
Other financing activities for Q1 2026 stood at $14000.0, down from $191000.0 in the prior quarter.
The five-year high for Other financing activities was $1.8 million in Q4 2022, with the low at -$147000.0 in Q4 2024.
The 5-year median for Other financing activities is $162000.0 (2023), against an average of $280846.2.
The sharpest annual moves came in 2022 and 2023: Other financing activities surged 14733.33% in 2022, then slumped 105.43% in 2023.
Seer's Other financing activities stood at $1.8 million in 2022, then plunged by 105.43% to -$95000.0 in 2023, then plunged by 54.74% to -$147000.0 in 2024, then soared by 229.93% to $191000.0 in 2025, then tumbled by 92.67% to $14000.0 in 2026.
Business Quant data shows SEER's Other financing activities at $14000.0 in Q1 2026, $191000.0 in Q4 2025, and $188000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Seer	230.63 Mn	230.63 Mn	1.51 Mn

Download Data